Download citation
Download citation

link to html
The structure of the title compound, 2-methyl-1-(1,2,3,9-tetra­hydro-9-methyl-4-oxo-4H-carbazol-3-yl­methyl)-1H-imid­azol-3-ium chloride dihydrate, C18H24N3+·Cl-·2H2O, has been reported previously by Collin, Moureau, Quintero, Vercauteren, Evrard & Durant [(1995). J. Chem. Soc. Perkin Trans. 2, pp. 77-84] and Chandra Mohan & Ravikumar, [(1995), Acta Cryst. C51, 2627-2629]. In both determinations, all atoms were refined as clearly ordered. In contrast to this, we present here a redetermination of this structure from new intensity data where two atoms of the cyclo­hexenone ring are disordered over two sites. Apart from this disorder, our results agree with the already published data.

Download citation
Download citation

link to html
The molecular structure of the title compound, C9H16O4, is described by a trans-planar configuration of the propyl chains. The mol­ecule has an approximate pseudo-twofold rotation axis in the crystal structure. The mol­ecules are interconnected by strong O—H...O hydrogen bonds and form an R22(8) ring structure.

Download citation
Download citation

link to html
The title compound [systematic name: (\pm)-5-({4-[2-(5-ethyl-2-pyridinio)­ethoxy]­phenyl}methyl)­thia­zolidine-2,4-dione chlor­ide], C19H21N2O3S+·Cl, is an oral antidiabetic agent. In the crystal structure, the mol­ecules are linked by N—H...Cl hydrogen bonds into chains.

Download citation
Download citation

link to html
The title compound [alternatively called 3-ethyl 5-methyl 4-(2-chloro­phenyl)-2-(2-phthalmidoethoxy­methyl)-6-methyl-1,4-di­hydro­pyridine-3,5-di­carboxyl­ate or ethyl methyl (4RS)-4-(2-chloro­phenyl)-2-({[2-(1,3-dioxo-1,3-di­hydro-2H-isoindol-2-yl)­ethyl]­oxy}methyl)-6-methyl-1,4-di­hydro­pyridine-3,5-di­carboxyl­ate], C28H27ClN2O7, is a calcium channel blocker and belongs to the family of anti-anginal and antihypertensive reagents. The di­hydro­pyridine ring adopts an envelope conformation. The molecular conformation is stabilized by an intramolecular N—H...O hydrogen bond.

Download citation
Download citation

link to html
The title compound, C8H7NO2, serves as an intermediate for the synthesis of citalopram. The packing of the planar mol­ecules is stabilized by N—H...O and N—H...N hydrogen bonds.

Download citation
Download citation

link to html
The title compound, C8H5BrO2, serves as a starting material for the synthesis of citalopram. It crystallizes with two almost identical mol­ecules in the asymmetric unit.

Download citation
Download citation

link to html
Supramolecular assembly of the title compound, C12H14ClFN2O, is primarily governed by N—H+...Cl and C—H...O interactions, and a putative C—H...F interaction. The piperidine ring assumes a chair conformation, with the substituted benzisoxazole ring in an equatorial position.

Download citation
Download citation

link to html
Sildenafil citrate is well known as Viagra for the treatment of erectile dysfuncion. In the title compound (systematic name: 1-{[3-(6,7-Di­hydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo­[4,3-d]­pyrimidin-5-yl)-4-ethoxy­phenyl]­sulfonyl}-4-methyl­piper­az­in­ium citrate monohydrate), C22H31N6O4S+·C6H7O7-·H2O, the pyrazolopyrimidone ring system and the benzene ring are almost coplanar, enabling an intramolecular hydrogen bond between the pyrazolopyrimidone NH group and the O atom of the ethoxy group. One of the N atoms of the piperazine ring is protonated and the citrate mol­ecule exists as an anion. The crystal packing is stabilized by several hydrogen bonds.

Download citation
Download citation

link to html
The title compound, C22H21ClN4O, is used as an intermediate for the synthesis of biologically active compounds. Geometric parameters are in the usual ranges. The packing is stabilized by O—H...N hydrogen bonding.

Download citation
Download citation

link to html
The title compound, C16H18N2O2, is a key intermediate for the synthesis of biologically active novel heterocycles, e.g. isoxazolines and isoxazoles. Geometric parameters of the mol­ecule are in the usual ranges. The crystal packing is stabilized by an O—H...N hydrogen bond.

Download citation
Download citation

link to html
The title compound, C33H25BrN4, belongs to the class of substituted tetrazoles. This type of compound is an important starting material for the synthesis of pharmaceutically active materials.

Download citation
Download citation

link to html
The title compound, C14H16N2, adopts a trans-planar conformation. However, the mol­ecule, which possesses Ci point group symmetry, crystallizes in the non-centrosymmetric space group P212121. In the crystal structure, the mol­ecular symmetry is only approximately retained. The crystal packing is predominantly stabilized by N—H...N hydrogen bonds. Weak C—H...π inter­actions also contribute to the stability.

Download citation
Download citation

link to html
Molecules of the title compound, C9H15NO3, form a two-dimensional hydrogen-bonded network, via O—H...O and N—H...O interactions, which runs parallel to the bc plane. In this structure, neither the carboxyl­ic acid groups nor the carbamoyl groups are involved in dimer formations.

Download citation
Download citation

link to html
The geometric parameters of the title compound, C11H10ClNO2, are in the normal ranges. The phthal­imide moiety is planar and the chloro­propyl chain adopts a synclinal conformation. The crystal packing is stabilized by two intermolecular C—H...O contacts.

Download citation
Download citation

link to html
The structure of the title compound, C13H16O4, comprises a non-planar chiral mol­ecule where the cyclo­hexene double bond is distinctly shorter [1.335 (2) Å] than the neighbouring C-C single bonds (>1.4 Å).

Download citation
Download citation

link to html
The title compound, C22H20ClN3O, (I), is used as an inter­mediate for the synthesis of the antihypertensive drug losartan. Bond lengths and angles are unexceptional. The crystal packing is stabilized by one C—H...O and one C—H...N contact. It is noteworthy that (I) is isomorphous with a closely related compound which differs in having a but-2-en­yl chain instead of a but­yl chain on the imidazole ring.

Download citation
Download citation

link to html
The asymmetric unit of the title compound, C16H15NO, comprises two independent mol­ecules (A and B), both adopting a half-boat conformation, or butterfly shape. The intramolecular dihedral angles between the benzene rings in A and B are 64.40 (4) and 65.24 (5)°, respectively.

Download citation
Download citation

link to html
The structure of the title compound, C15H13NO, has six independent mol­ecules in the asymmetric unit; in each case, the seven-membered ring adopts a boat conformation and the overall molecular shape is that of a butterfly. All mol­ecules display N—H...C=C close contacts, instead of N—H...O interactions. The intramolecular dihedral angles between the benzene rings are within the range 43.7 (1)–46.4 (1)° for the six mol­ecules.

Download citation
Download citation

link to html
The structure of the title compound, C16H14N2O2, contains a seven-membered ring that adopts a boat conformation, and the overall molecular shape is that of a butterfly. In the packing, the mol­ecules form a convoluted hydrogen-bonded polymer via a typical R22(8) graph-set dimer, between carbox­amide groups, and an R22(16) graph-set dimer formed through an interaction between the second carbox­amide NH group and an adjacent methoxy O atom (in each mol­ecule). The dihedral angle between the benzene rings is 56.09 (5)°.

Download citation
Download citation

link to html
In the title compound, C13H15N3O2S, the geometric parameters are in the normal ranges. The amide N atom is coordinated in an almost trigonal-planar fashion.
Follow Acta Cryst. E
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds